Fisiopatología e Investigación Clínica de las Enfermedades de Base Inmunológica e Inflamatoria Crónicas

Vaquero-Yuste, C; Juarez, I; Molina-Alejandre, M; Gutiérrez-Calvo, A; Lopez-García, A; Lasa, I; Gomez, R; Arnaiz-Villena, A; Martín-Villa, JM.

Hampered CD8+ILT2+T cell activation by HLA-G suggests a new immune checkpoint in gastric adenocarcinoma

Gastric Cancer. 2025; : [doi:10.1007/s10120-025-01689-5]

García-Martínez, E; Nieto-Valle, A; Barrio-Alonso, C; López-Navarro, B; Avilés-Izquierdo, JA; Parra-Blanco, V; Gutiérrez-Seijo, A; Sánchez-Mateos, P; Samaniego, R.

Adverse prognosis of GM-CSF expression in human cutaneous melanoma

NEOPLASIA. 2025; 70: [doi:10.1016/j.neo.2025.101240]

Arnaiz-Villena, A; Juarez, I; Vaquero-Yuste, C; Lledo, T; Martín-Villa, JM; Suarez-Trujillo, F.

Two different complement Factor B (Bf) alleles of the orangutan major histocompatibility complex (MHC) are also conserved in chimpanzee and humans showing importance in primate immunity

MOLECULAR BIOLOGY REPORTS. 2025; 52(1): [doi:10.1007/s11033-024-10086-7]

Portela-Sánchez, S; Catalina, I; Muñoz, SL; Ros, AL; Sánchez-Soblechero, A; Vendrel, ES; Sánchez-Mateos, P; Muñoz-Blancoa, JL.

Immune-mediated necrotizing myopathy: experience in a neuromuscular unit

NEUROLOGIA. 2025; 40(8): 729-738 [doi:10.1016/j.nrl.2023.03.005]

Alba-Cano, T; Alonso, R; Balastegui-Martín, H; Bravo-Gallego, LY; Sánchez-Mateos, P; Martín-López, M; Gil-Herrera, J.

Impact of CMV latency on T-cell responses to COVID-19 vaccination among predominantly antibody-deficient patients

Frontiers in Immunology. 2025; 16: [doi:10.3389/fimmu.2025.1659259]

Zhang, FH; Al-Amin, MY; Utturkar, S; Jiang, RA; Cresswell, G; Alfar, R; Ophaug-Johansen, I; Bachman, G; Srinivasarao, M; Finnell, R; Puig-Kröger, A; Ratliff, T; Low, PS.

Folate receptor ß performs an immune checkpoint function in activated macrophages

Frontiers in Immunology. 2025; 16: [doi:10.3389/fimmu.2025.1638907]

Martínez-López, S; Juanola, O; Gómez-Hurtado, I; Angel-Gomis, E; Boix, P; Fernández-Iglesias, A; Gallardo-Cruz, A; Cubero, FJ; Gracia-Sancho, J; Puig-Kröger, A; Caparrós, E; Francés, R.

LSECtin attenuates hepatic Th17 expansion in a murine model of cirrhosis and signals through the LAG-3 receptor

Jhep Reports. 2025; 7(9): [doi:10.1016/j.jhepr.2025.101482]

García-Martínez, E; Schiaffino, MT; Di Natale, M; Luna, MDD; Alvarez, DAV; González, MAM.

From syndromic clues to diagnosis: understanding CARD11-driven disorders

Frontiers in Immunology. 2025; 16: [doi:10.3389/fimmu.2025.1626065]

Sánchez, MS; Garcia-Martínez, E; Martín, HB; Durán-García, ME; Olleros, CL.

Use of anakinra in cryopyrin-associated periodic syndromes: case report and review of literature

Frontiers in Immunology. 2025; 16: [doi:10.3389/fimmu.2025.1591234]

Rios, I; Herrero, C; Torres-Torresano, M; López-Navarro, B; Schiaffino, MT; Crespo, FD; Nieto-Valle, A; Samaniego, R; Sierra-Palomares, Y; Oliver, E; Revuelta-Salgado, F; García-Luján, R; Sánchez-Mateos, P; Delgado, R; Puig-Kröger, A; Corbi, AL.

Reprogramming of GM-CSF-dependent alveolar macrophages through GSK3 activity modulation

eLife. 2025; 14: [doi:10.7554/eLife.102659]

Barrio-Alonso, C; Nieto-Valle, A; Barandalla-Revilla, L; Avilés-Izquierdo, JA; Parra-Blanco, V; Sánchez-Mateos, P; Samaniego, R.

Translating genetics into tissue: inflammatory cytokine-producing TAMs and PD-L1 tumor expression as poor prognosis factors in cutaneous melanoma

Frontiers in Immunology. 2025; 16: [doi:10.3389/fimmu.2025.1587545]

Garate-Soraluze, E; Serrano-Mendioroz, I; Fernández-Rubio, L; De Andrea, CE; Barrio-Alonso, C; Herrero, CD; Teijeira, A; Luri-Rey, C; Claus, C; Tanos, T; Klein, C; Umana, P; Rullan, A; Simón, JA; Collantes, M; Sánchez-Mateos, P; Melero, I; Rodriguez-Ruiz, ME.

4-1BB agonist targeted to fibroblast activation protein a synergizes with radiotherapy to treat murine breast tumor models

Journal for ImmunoTherapy of Cancer. 2025; 13(1): Nº de citas: 2 [doi:10.1136/jitc-2024-009852]

Molina-Alejandre, M; Juárez, I; Vaquero-Yuste, C; Gorroño-Echebarría, M; Molanes-López, EM; Fernandez-Cruz, E; Rodriguez-Sainz, C; Arnaiz-Villena, A; Martin-Villa, JM.

HLA-G Polymorphisms of The 3'-UTR Region Are Involved in Susceptibility to Non-Infectious Uveitis

OCULAR IMMUNOLOGY AND INFLAMMATION. 2025; 33(5): 806-811 [doi:10.1080/09273948.2025.2455969]

Bourgeois, C; Sánchez-Lucas, M; Olmedo-Galindo, J; Schiaffino, MT; del Río, T; Molina-Collada, J; Martínez-Barrio, J; Fernández-Plana, G; Rivera, J; Alvaro-Gracia, JM; Castrejon, I.

Improving early referrals for inflammatory arthritis through primary care engagement: a quality improvement initiative

Rheumatology Advances In Practice. 2025; 9(4): [doi:10.1093/rap/rkaf129]

López-Navarro, B; Simón-Fuentes, M; Ríos, I; Schiaffino, MT; Sanchez, A; Torres-Torresano, M; Nieto-Valle, A; Castrejón, I; Puig-Kröger, A.

Macrophage re-programming by JAK inhibitors relies on MAFB

CELLULAR AND MOLECULAR LIFE SCIENCES. 2024; 81(1): Nº de citas: 9 [doi:10.1007/s00018-024-05196-1]

Vaquero-Yuste, C; Juarez, I; Molina-Alejandre, M; Molanes-López, EM; Gutiérrez-Calvo, A; López-García, A; Lasa, I; Gómez, R; Arnaiz-Villena, A; Martín-Villa, JM.

HLA-G high-expressor 3'UTR markers are linked to gastric cancer development and survival

CANCER IMMUNOLOGY IMMUNOTHERAPY. 2024; 74(1): Nº de citas: 1 [doi:10.1007/s00262-024-03771-w]

Martínez-López, S; García-Gutiérrez, MS; Navarrete, F; Gómez-Hurtado, I; Zapater, P; Angel, E; Juanola, O; López-Cánovas, J; Boix, P; Hadid, MC; Puig-Kröger, A; Gahete, MD; Manzanares, J; Caparrós, E; Francés, R.

Aging Deteriorates Blood Brain Barrier Function and Polarizes Adaptive T Cell Expansion Contributing to Neurocognitive Damage in Experimental Cirrhosis

Aging and Disease. 2024; : [doi:10.14336/AD.2024.0932]

Briones, AC; Megino, RF; Marin, AV; Chacón-Arguedas, D; García-Martinez, E; Balastegui-Martín, H; Reyburn, HT; Henrickson, SE; Rodríguez-Sainz, C; Seoane-Reula, E; Sanchez-Mateos, P; Cardenas, PP; Regueiro, JR.

Nonsense CD247 mutations show dominant- negative features in T-cell receptor expression and function

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. 2024; 154(4): Nº de citas: 2 [doi:10.1016/j.jaci.2024.06.019]